AdvaMed Asks White House, FDA for Help to Keep U.S. Leadership

In light of increasing competition from developing nations, AdvaMed released a “competitiveness agenda” to maintain the U.S.’ role as a leader in the device industry. The agenda includes wide-ranging policy recommendations to improve government support of device innovation via shorter FDA review times and reimbursement reform.
International Medical Device Regulatory Monitor